Boehringer Ingelheim BioXcellence is the contract-manufacturing arm of Boehringer Ingelheim, one of the largest antibody producers by volume.
Boehringer Ingelheim BioXcellence, based in Ingelheim, is the contract manufacturing arm of Boehringer Ingelheim, one of the largest antibody producers by volume. It offers mammalian and microbial biologics manufacturing in Germany, Austria, China and the United States. OnCo links it to antibody manufacturing through CHO bioprocessing. Whether a pharmaceutical company can run a contract manufacturing business for competitors without conflicts over capacity is the fair question. The antibody manufacturing page carries the wider picture.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing).
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Antibody manufacturing (CHO bioprocessing), Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Shares Downstream purification (Protein A capture, viral clearance, polishing) and the tag supporting.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/